Ads
related to: stryker hip recall fda
Search results
Results From The WOW.Com Content Network
On 2012, FDA has issued a warning for the Stryker Rejuvenate hip replacement after it was discovered that the hip replacement was considered defective and can cause similar side effects to DePuy hip implants. As a result, in 2014, Stryker was fined 1 billion and 2.5 billion respectively for their defective Rejuvenate and ABG II hip replacements ...
Lawsuits are a way of life for any health-care company, a reality that's particularly evident in the medical-devices sector. For an example, you don't need to look any further than the orthopedic ...
For premium support please call: 800-290-4726 more ways to reach us
On August 24, 2010, DePuy recalled [4] all ASR hip implant systems sold since 2003. The 2010 DePuy Hip Recall was issued after research released by the National Joint Registry (NJR) found high rates of hip replacement failure for the ASR XL Acetabular and ASR Hip Resurfacing systems.
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson & Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. [1] [2]
Natus Comments on FDA Recall SAN CARLOS, Calif.--(BUSINESS WIRE)-- Natus Medical Incorporated (NAS: BABY) today released a statement regarding the issuance by the Food & Drug Administration (the ...
FDA confronted these executives about whether [its] corporate culture supported a robust quality system to ensure the purity, potency and safety of its products.” Among the cultural issues Sharfstein raised was what he called J&J’s “phantom recall” of Motrin tablets in the spring of 2009.
Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. [1] Hip replacement surgery can be performed as a total replacement or a hemi/semi(half) replacement. Such joint replacement orthopaedic surgery is generally conducted to relieve arthritis pain or in some hip fractures.